News

Digital/ News/ News/ News/ News/ R&D/ Startups/ Top stories

European VCs ‘actively seeking new healthcare investments’

Phil Taylor Europe, investment, Life Sciences, venture capital 0 Comment

The disruption caused by the coronavirus crisis hasn’t dampened the enthusiasm of European venture capitalists to make funding

European VCs ‘actively seeking new healthcare investments’

https://pharmaphorum.com/news/european-vcs-actively-seeking-new-healthcare-investments/

News/ News/ News/ Oncology/ Startups

AbbVie leads $53m investment macrophage cancer tech

Piotr Wnuk AbbVie, cancer, Carisma Therapeutics, Oncology 0 Comment

A duo of University of Pennsylvania scientists have stepped out with multi-million dollar backing from investors including AbbVie,

AbbVie leads $53m investment macrophage cancer tech

https://pharmaphorum.com/news/53m-investment-carisma-therapeutics/

Digital/ News/ News/ News/ Startups

Alphabet/AMA challenge startups to improve health data sharing

Richard Staines digital health, digital startups 0 Comment

Google’s parent company Alphabet is partnering with the American Medical Association to promote a challenge encouraging startups to

Alphabet/AMA challenge startups to improve health data sharing

https://pharmaphorum.com/news/alphabet-ama-challenge-startups-improve-health-data-sharing/

News/ News/ Startups/ US

Aimmune to file peanut allergy treatment by year-end

Richard Staines allergy, Biotech, R&D 0 Comment

Backed by a $202 million fundraiser, biotech Aimmune has announced plans to file its potential peanut allergy treatment at the end of the year following a phase 3 trial success.

Aimmune to file peanut allergy treatment by year-end

https://pharmaphorum.com/news/aimmune-to-file-peanut-allergy-treatment-at-year-end/

Cancer/ Digital and Social Media/ Healthcare/ News/ News/ News/ R&D/ R&D/ Startups/ UK & Europe

Breath Biopsy company adds new investor to $15m fundraising

Andrew McConaghie diagnostics, digital health, Owlstone Medical 0 Comment

Owlstone Medical, the innovative company which promises to revolutionise the diagnosis of cancer by simply analysing a patient’s breath has been given a major funding boost.

Breath Biopsy company adds new investor to $15m fundraising

https://pharmaphorum.com/news/breath-biopsy-company-adds-new-investor-15m-fundraising/